Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer.

导出 OA

翻译打印收藏纠错

作者： Jun,Wang ^[1] ; Na,Sun ^[1] ; Thomas,Kunzke ^[1] ; Jian,Shen ^[1] ; Annette,Feuchtinger ^[1] ; Qian,Wang ^[1] ; Raphael,Meixner ^[2] ; Ronan Le,Gleut ^[2] ; Ivonne,Haffner ^[3] ; Birgit,Luber ^[4] ; Florian,Lordick ^[3] ; Axel,Walch ^[5]

作者单位： Research Unit Analytical Pathology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany. ^[1] Core Facility Statistical Consulting, Helmholtz Zentrum München, 85764, Neuherberg, Germany. ^[2] University Cancer Center Leipzig (UCCL), Leipzig University Medical Center, Leipzig, Germany. ^[3] Technische Universität München, Fakultät für Medizin, Klinikum rechts der Isar, Institut für Allgemeine Pathologie und Pathologische Anatomie, München, Germany. ^[4] Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Diseases, Leipzig University Medical Center, Leipzig, Germany. ^[5] Research Unit Analytical Pathology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany. axel.walch@helmholtz-muenchen.de. ^[6]

主题词人类(Humans);胃肿瘤(Stomach Neoplasms);前瞻性研究(Prospective Studies);治疗结果(Treatment Outcome);预后(Prognosis)

DOI 10.1038/s41416-023-02559-6

PMID 38267634

发布时间 2024-03-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交